Two MIT seniors and alumnus Noam Angrist have been named Rhodes Scholars, reports Dave Collins for the Associated Press. “It’s a total dream come true,” says Angrist. “The skills I will get at (Oxford) are just incredible, and I’ll come back into the world fully equipped to do what I love to do.”
Prof. Robert Langer speaks with Trisha Gura of Science about his work as an engineer and entrepreneur. Says Langer of how he became an entrepreneur, “I could see that by having these little companies, you could make an enormous impact.”
Boston Globe reporter Callum Borchers writes about how MIT researchers have developed a new coating that could reduce the risk posed by ingesting batteries. The battery has “been shown in lab tests to deactivate an ingested battery without compromising its performance in electronic devices,” writes Borchers.
In a piece for The Boston Globe, Meredith Goldstein writes that Institute Professor Robert Langer received a Kyoto Prize at a ceremony in Japan for his work with tissue engineering.
In a piece for The Atlantic, Sarah Laskow writes about how MIT researchers have developed a new drug-delivery capsule that could serve as an alternative to injections. The new drug capsule would make it possible to “deliver drugs that would otherwise break down in the digestive tract.”
Reporting for Scientific American, Cynthia Graber examines how MIT researchers have developed a battery coating that reduces the risk of injury if swallowed. Inside the coating, “microparticles of conductive metal are suspended in an insulating layer,” Graber explains.
BBC News reporter Jonathan Webb writes that researchers from MIT have created child-safe batteries by developing a coating that allows batteries to conduct electricity only when squeezed. The “pressure-sensitive design makes use of a property called quantum tunneling, which is also used in touch pads and screens,” writes Webb.
Alison Bruzek of NPR reports that MIT researchers have developed a shield that can prevent the electrical currents in a battery from damaging the esophagus. The material used to create the shield is already commercially available, NPR reports, making the coating a cheap solution to the issue of children swallowing batteries.
Atlantic reporter Cari Romm reports on how MIT researchers have devised an alternative drug-delivery method: A pill covered with tiny needles. The researchers plan to improve their current design by creating a “fully biodegradable version of the pill.”
Niina Heikkinen reports for Scientific American that MIT researchers have identified a new way to make yeast more ethanol-tolerant. The researchers were able to improve “alcohol tolerance and extend the amount of time that individual cells could produce ethanol.”
WCVB reports that researchers from MIT and Massachusetts General Hospital have developed a pill coated with tiny needles that can deliver drugs directly into the digestive tract. The pill was found to deliver insulin more efficiently than current methods, WCVB reports.
“Researchers at the Massachusetts Institute of Technology have developed a pill-like capsule that injects medication into the stomach lining after being swallowed,” reports Sky News. The new capsule could allow for oral delivery of drugs that currently must be injected.
MIT scientists have developed a pill coated in tiny needles that allows medicine to be absorbed through the lining of the stomach, writes Brooks Hays of UPI. Initial trials showed that the pill delivered insulin more efficiently than an injection.
Thomas Burton of The Wall Street Journal writes that MIT researchers were among those awarded the first research grants under President Obama’s new BRAIN Initiative. Burton writes that one of the MIT grants will go toward “determining which exact brain circuits are involved in generating short-term memories that influence decisions.”
Boston Globe reporter Deborah Kotz writes that MIT researchers have been awarded new grants from the National Institutes of Health to further brain research. “Biophysicist Alan Jasanoff received a grant to develop imaging agents for functional MRI imaging that would target the flow of calcium into and out of brain cells,” writes Kotz of one of the MIT grants.